Plasma Protein Binding Of Drugs/ (PPB)of drugs in pharmacology/

Поділитися
Вставка
  • Опубліковано 9 вер 2024
  • Plasma protein binding refers to the degree to which medications attach to proteins within the blood. A drug's efficiency may be affected by the degree to which it binds. The less bound a drug is, the more efficiently it can traverse cell membranes or diffuse. Common blood proteins that drugs bind to are human serum albumin, lipoprotein, glycoprotein, and α, β‚ and γ globulins.
    A drug in blood exists in two forms: bound and unbound. Depending on a specific drug's affinity for plasma protein, a proportion of the drug may become bound to plasma proteins, with the remainder being unbound. If the protein binding is reversible, then a chemical equilibrium will exist between the bound and unbound states, such that:
    Protein + drug ⇌ Protein-drug complex
    Notably, it is the unbound fraction which exhibits pharmacologic effects. It is also the fraction that may be metabolized and/or excreted. For example, the "fraction bound" of the anticoagulant warfarin is 97%. This means that of the amount of warfarin in the blood, 97% is bound to plasma proteins. The remaining 3% (the fraction unbound) is the fraction that is actually active and may be excreted. Note that this does not mean that 97% of the plasma proteins are bound with drug, however.
    Protein binding can influence the drug's biological half-life. The bound portion may act as a reservoir or depot from which the drug is slowly released as the unbound form. Since the unbound form is being metabolized and/or excreted from the body, the bound fraction will be released in order to maintain equilibrium.
    Since albumin is alkalotic, acidic and neutral drugs will primarily bind to albumin. If albumin becomes saturated, then these drugs will bind to lipoprotein. Basic drugs will bind to the acidic alpha-1 acid glycoprotein. This is significant because various medical conditions may affect the levels of albumin, alpha-1 acid glycoprotein, and lipoproteins.
    Impact of the altered protein bindingEdit
    Only the unbound fraction of the drug undergoes metabolism in the liver and other tissues. As the drug dissociates from the protein, more and more drug undergoes metabolism. Changes in the levels of free drug change the volume of distribution because free drug may distribute into the tissues leading to a decrease in plasma concentration profile. For the drugs which rapidly undergo metabolism, clearanceis dependent on the hepatic blood flow. For drugs which slowly undergo metabolism, changes in the unbound fraction of the drug directly change the clearance of the drug.
    Note: The most commonly used methods for measuring drug concentration levels in the plasma measure bound as well as unbound fractions of the drug.
    The fraction unbound can be altered by a number of variables, such as the concentration of drug in the body, the amount and quality of plasma protein, and other drugs that bind to plasma proteins. Higher drug concentrations would lead to a higher fraction unbound, because the plasma protein would be saturated with drug and any excess drug would be unbound. If the amount of plasma protein is decreased (such as in catabolism, malnutrition, liver disease, renal disease), there would also be a higher fraction unbound. Additionally, the quality of the plasma protein may affect how many drug-binding sites there are on the protein.
    Drug interaction:
    Using 2 drugs at the same time can sometimes affect each other's fraction unbound. For example, assume that Drug A and Drug B are both protein-bound drugs. If Drug A is given, it will bind to the plasma proteins in the blood. If Drug B is also given, it can displace Drug A from the protein, thereby increasing Drug A's fraction unbound. This may increase the effects of Drug A, since only the unbound fraction may exhibit activity.

КОМЕНТАРІ • 10

  • @sanjaygatade7986
    @sanjaygatade7986 3 роки тому +2

    Very nice Sir

  • @mahi_in_wilderness
    @mahi_in_wilderness 3 роки тому +3

    Awesome!! One of the best lectures I have watched. I am still not able to figure out the unbound Cmax in plasma of a drug at a recommended concentration of 400mg and Cmax = 2830 ng/mL. Plasma protein binding given is 97%.
    Since plasma protein binding is 97%, so unbound will be = 3%. To find Unbound Cmax: it will be = 3 *2830/100 = 84.9 ng/mL. Is this correct?
    Please help!!!

    • @DrNITINPURAM
      @DrNITINPURAM  3 роки тому +2

      Absolutely... Correct..

    • @DrNITINPURAM
      @DrNITINPURAM  3 роки тому +1

      Mahi... Please share this video.. with ur friends on all what's app group....

    • @mahi_in_wilderness
      @mahi_in_wilderness 3 роки тому

      @@DrNITINPURAM Definitely!!

    • @mahi_in_wilderness
      @mahi_in_wilderness 3 роки тому

      @@DrNITINPURAM Thank you for the quick response!! I have another follow-up question.
      I want to compare it with EC50 value which is 0.4nmol/L. I am having difficulty in converting the units. Will you be able to help. Please!!

    • @mahi_in_wilderness
      @mahi_in_wilderness 3 роки тому

      any help on this??

  • @needsomehelp12
    @needsomehelp12 3 роки тому +2

    Sir my doctor misdiagnosed my allergy with covid..he gave me 1800mg two times for first day and later 800 mg two times for 5 days..will I get sideeffects in future and if yes how do I monitor them

    • @DrNITINPURAM
      @DrNITINPURAM  3 роки тому +1

      No...need to worry about about side effects in future...once treatment is over...

  • @islamicfollower7654
    @islamicfollower7654 3 роки тому +1

    Can you Send me pdfs.i can give email Id